Summary ToggleIntricon Reports Third Quarter 2020 Results

ARDEN HILLS, Minn. , Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intri c on Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its third Read More

Summary ToggleIntriCon Reports Second Quarter 2020 Results

ARDEN HILLS, Minn. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its second Read More

Summary ToggleIntriCon Announces Chief Executive Officer Transition

J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020 ARDEN HILLS, Minn. , June 25, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today Read More

Summary ToggleIntriCon Reports First Quarter 2020 Results

ARDEN HILLS, Minn. , May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2020 . Read More

Summary ToggleIntriCon Acquires Emerald Medical Services

Synergistic joint development and manufacturing capability expands market opportunity in surgical navigation Provides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters   Accretive transaction delivers long-term revenue growth Read More